Back to the IMF web site.
IMF Store Home
Clothing & Accessories
Gifts & Other Merchandise
Free Publications
IMF Videos
IMF Grant Applications
Myeloma Manager
[View Cart]
   

Free Publications

IMF publications are a valuable resource for patients, family members and medical professionals.
 
INFO PACK
The IMF Info Pack provides comprehensive information on treatment options and disease management. Available free of charge, the Info Pack includes The IMF Patient Handbook and The IMF Concise Review of the Disease and Treatment Options, as well as many of the important Understanding Series booklets. Click on the thumbnail to the left to see a complete list of the publications included in the Info Pack.
 
Patient Handbook2015_ShopSite.png PATIENT HANDBOOK
The Patient Handbook provides a basic understanding of myeloma to allow patients to make informed decisions about treatment choices.

Choose a Language:
Quantity   
 
ConciseReview_ShopSite.png Concise Review of the Disease and Treatment Options
The IMF Concise Review of the Disease and Treatment Options is an overview of the history of myeloma, a discussion of pathophysiology, clinical features, and treatment options. It is written primarily for health professionals who treat myeloma, but perhaps not on a routine basis.

Choose a Language:
Quantity   
 
U-Adherance_2015_shopsite.png Understanding Adherence to Oral Cancer Therapy
$0.00
This booklet is intended to help myeloma patients and their healthcare providers work together to overcome any and all obstacles to adherence to safe and effective oral cancer therapy. It will help patients understand potential obstacles to complying with a doctor’s treatment plan in order to achieve the best results.
 
U-Bisphosphonates_2016_shopsite.png Understanding Bisphosphonate Therapy
This booklet is devoted to therapy that is given to patients with myeloma bone involvement. Approximately 80% of myeloma patients develop bone disease. Bisphosphonates help to prevent skeletal complications of myeloma. Treatment with bisphosphonates reduces bone damage and, when the myeloma is well controlled, allows bone healing to occur.
Quantity   
 
U-ClinicalTrials_2015_shopsite.png Understanding Clinical Trials
$0.00
Clinical trials are used to further test new medications and therapies on human subjects. Whether or not to participate in a clinical trial is one of the critical decisions you and your oncologist may have to make in the course of your cancer treatment.
 
U-Dexamethasone2016_shopsite.png Understanding Dexamethasone and Other Steroids
After reading this booklet, you should know what dexamethasone is, how it works, possible side effects, and more.

Choose a Language:
Quantity   
 
U-Empliciti_2016_thumb.png Understanding Empliciti
$0.00
This booklet discusses the new drug Empliciti® (known also by its generic name, elotuzumab): the way it works, the results of clinical trials with Empliciti, how and when Empliciti is administered, the possible side effects of Empliciti, and how to manage those side effects.
 
U_Fatigue_2015_shop.png Understanding Fatigue
$0.00
This booklet contains a thorough examination of coping strategies and causes of myeloma fatigue, as well as suggestions for discussing fatigue with your doctor. Myeloma patients may experience fatigue caused by the disease, by treatment, and by the understandable anxiety and/or depression that affects many.
 
U-Freelite_Hevylite_2016_shop.png Understanding Freelite and Hevylite Tests
$0.00
This booklet is devoted to two tests used in the diagnosis and monitoring of myeloma, the serum free light chain assay (Freelite®) and the serum heavy/light chain assay (Hevylite®). Since Freelite and Hevylite are independent biomark­ers of disease activity, it is important to monitor patients with both tests.
 
U-StemCell2016_shopsite.png Understanding High-Dose Therapy with Stem Cell Rescue
$0.00
High-dose therapy with stem cell rescue, or "stem cell transplant," is an important treatment option for eligible patients with multiple myeloma.
 
U-ImmuneSystem_body.jpg Understanding the Immune System in Multiple Myeloma
$0.00
This booklet will help you understand immune system basics. The immune system is extremely complex. It is made up of multiple mechanisms that work together to protect and defend the human body from external threats such as bacteria, viruses, and toxins, and from internal threats such as cancer.
 
U-Kyprolis2016_shopsite.png Understanding Kyprolis� (carfilzomib) for Injection
This booklet discusses Kyprolis�, the results of clinical trials with Kyprolis, how and when it is administered, its possible side effects, and how to manage them.
Quantity   
 
U_MGUS2015_shop.png Understanding MGUS and Smoldering Myeloma
$0.00
This booklet contains information about monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Neither is an active disease state, but both are precursor states to active myeloma. It is therefore important to understand if, when, and how active myeloma might evolve and what monitoring and/or interventions are appropriate.
 
U-ninlaro_2016_shop.png Understanding Ninlaro
$0.00
Ninlaro is the first oral proteasome inhibitor approved by the FDA to treat multiple myeloma. It is the third drug in the proteasome inhibitor class that has been approved for MM. Ninlaro is indicated for myeloma patients who have received at least one prior therapy.
 
U-Pomalyst_2015_shopsite.png Understanding Pomalyst®
(pomalidomide) capsules

Pomalyst in combination with dexamethasone was approved by the U.S. Food and Drug Administration (FDA) on February 8, 2013 for relapsed and refractory myeloma.
Quantity   
 
U-Revlimid_2015_shopsite.png Understanding Revlimid�
Revlimid� (lenalidomide) has been approved by the FDA for use in myeloma.

Choose a Language:
Quantity   
 
U-TestResults_2016_shop.png Understanding Your Test Results
$0.00
This booklet outlines the tests that are used to diagnose and monitor myeloma, and to detect response and relapse. No single study is adequate to tell the whole story about a patient’s status but, used together, test results give a more complete picture.
 
U-thal_2015_shopsite.png Understanding Thalidomide Therapy
Using thalidomide to treat myeloma is a new idea, but thalidomide itself has been studied for many decades. Much has been learned about how thalidomide works in the treatment of different diseases, and how its side effects can be treated.

Choose a Language:
Quantity   
 
U-VertebralCompressionFractures_2016_shop.png Understanding Treatment of Myeloma-Induced Vertebral Compression Fractures
$0.00
As treatment for myeloma improves and patients live longer, it is important to reduce the disability that can result from the painful problem of vertebral compression fractures, which occur when the vertebra collapses or fractures because the bone is too weak to withstand the pressure or stress placed upon it.
 
U-Velcade_thumb.jpg Understanding VELCADE� (bortezomib) for Injection
This booklet covers the basics of FDA approved VELCADE�, including how it works, how it is administered, how is it used in clinical practice today, and side effects.
Quantity